Immucell Corp
Animal health biologics company developing, manufacturing and commercializing products that improve the health and productivity of neonatal dairy and beef calves, including the First Defense product line
All shares held by the Reporting Person are held by the Reporting Person for investment purposes. The Reporting Person currently has no plans or proposals that relate to, or would result in, any of the matters described in subsections (a) through (j) of Item 4 of the instructions to Schedule 13D.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| Ejnar A. Knudsen III | 13D/AActivist | 9.21% | 832.8K | Nov 20, 2025 |
All shares held by the Reporting Person are held by the Reporting Person for investment purposes. The Reporting Person currently has no plans or proposals that relate to, or would result in, any of the matters described in subsections (a) through (j) of Item 4 of the instructions to Schedule 13D. | ||||